van de Putte Lb

557 total citations
28 papers, 452 citations indexed

About

van de Putte Lb is a scholar working on Rheumatology, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, van de Putte Lb has authored 28 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 5 papers in Surgery and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in van de Putte Lb's work include Rheumatoid Arthritis Research and Therapies (10 papers), Osteoarthritis Treatment and Mechanisms (6 papers) and Orthopedic Infections and Treatments (5 papers) van de Putte Lb is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Osteoarthritis Treatment and Mechanisms (6 papers) and Orthopedic Infections and Treatments (5 papers) van de Putte Lb collaborates with scholars based in Netherlands, United Kingdom and Japan van de Putte Lb's co-authors include van Riel Pl, Joost Schalkwijk, Maries van den Broek, Müller Wh, P. Reekers, Jan P. Vandenbroucke, E.L. Vitters, I. H. Nuver-Zwart, F Eulderink and Annemieke Cats and has published in prestigious journals such as The Journal of Rheumatology and PubMed.

In The Last Decade

van de Putte Lb

28 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
van de Putte Lb Netherlands 11 246 130 65 58 53 28 452
K Merétey Hungary 12 107 0.4× 165 1.3× 55 0.8× 73 1.3× 68 1.3× 54 432
Strieter Rm United States 7 90 0.4× 136 1.0× 80 1.2× 37 0.6× 33 0.6× 7 402
Antti Kuuliala Finland 15 258 1.0× 142 1.1× 79 1.2× 61 1.1× 37 0.7× 36 581
A Peltier France 11 92 0.4× 143 1.1× 42 0.6× 89 1.5× 79 1.5× 29 354
Hiroshi Nagaya United States 15 146 0.6× 118 0.9× 105 1.6× 39 0.7× 28 0.5× 47 762
Germuth Fg United States 14 83 0.3× 115 0.9× 79 1.2× 33 0.6× 96 1.8× 22 542
W. R. M. Alexander United Kingdom 12 168 0.7× 63 0.5× 26 0.4× 50 0.9× 60 1.1× 21 376
Rosamond Janis United States 11 135 0.5× 62 0.5× 106 1.6× 17 0.3× 19 0.4× 19 404
Martti Nissilä Finland 10 594 2.4× 109 0.8× 60 0.9× 214 3.7× 38 0.7× 15 765
Veys Em Belgium 15 610 2.5× 278 2.1× 72 1.1× 156 2.7× 79 1.5× 34 913

Countries citing papers authored by van de Putte Lb

Since Specialization
Citations

This map shows the geographic impact of van de Putte Lb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by van de Putte Lb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites van de Putte Lb more than expected).

Fields of papers citing papers by van de Putte Lb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by van de Putte Lb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by van de Putte Lb. The network helps show where van de Putte Lb may publish in the future.

Co-authorship network of co-authors of van de Putte Lb

This figure shows the co-authorship network connecting the top 25 collaborators of van de Putte Lb. A scholar is included among the top collaborators of van de Putte Lb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with van de Putte Lb. van de Putte Lb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lb, van de Putte, et al.. (1997). The U1 snRNP complex: an autoantigen in connective tissue diseases. An update.. PubMed. 15(5). 549–60. 42 indexed citations
2.
Pl, van Riel & van de Putte Lb. (1994). DC-ART: what proportion of response constitutes a positive response?. PubMed. 41. 54–5; discussion 56. 5 indexed citations
3.
Kirwan, John, et al.. (1994). DC-ART: preventing or significantly decreasing the rate of progression of structural joint damage.. PubMed. 41. 36–40. 5 indexed citations
4.
Lb, van de Putte, et al.. (1994). Early cartilage degradation in cationic immune complex arthritis in mice: relative role of interleukin 1, the polymorphonuclear cell (PMN) and PMN elastase.. PubMed. 21(2). 321–9. 8 indexed citations
5.
Pl, van Riel, et al.. (1993). Validity of single variables and indices to measure disease activity in rheumatoid arthritis.. PubMed. 20(3). 538–41. 71 indexed citations
6.
Pl, van Riel, et al.. (1990). [Rheumajecta and Vasolastine treatment of primary fibromyalgia; results of a randomized placebo-controlled double-blind study].. PubMed. 134(14). 693–7. 4 indexed citations
7.
Broek, Maries van den, et al.. (1988). The role of mast cells in antigen induced arthritis in mice.. The Journal of Rheumatology. 15(4). 544–51. 37 indexed citations
8.
Lb, van de Putte, et al.. (1987). Electrical charge and joint inflammation. Suppression of cationic aBSA-induced arthritis with a competitive polycation.. PubMed. 127(1). 15–26. 4 indexed citations
9.
Vitters, E.L., et al.. (1986). The effect of salicylate on anatomically intact articular cartilage is influenced by sulfate and serum in the culture medium.. PubMed. 13(4). 686–93. 17 indexed citations
10.
Pl, van Riel, et al.. (1983). Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities.. PubMed. 10(2). 222–6. 23 indexed citations
11.
Pl, van Riel, et al.. (1983). Cell-bound gold (CBG) in patients treated with aurothioglucose and with auranofin. A comparison of different methods of determination.. PubMed. 10(4). 574–8. 6 indexed citations
12.
Lb, van de Putte, et al.. (1983). Thrombotic thrombocytopenic purpura associated with D-penicillamine treatment in rheumatoid arthritis.. PubMed. 9(5). 812–3. 10 indexed citations
13.
Reekers, P., et al.. (1983). HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis.. PubMed. 10(6). 948–53. 29 indexed citations
14.
Lb, van de Putte, et al.. (1982). Antigen induced arthritis: antigen handling and chronicity of joint inflammation.. PubMed. 11. 233–41. 6 indexed citations
15.
Lb, van de Putte, et al.. (1981). Antigen handling in antigen-induced joint inflammation: kinetics of a second intra-articularly injected dose of antigen in an already established antigen-induced joint inflammation.. PubMed. 44(1). 153–61. 10 indexed citations
16.
Eulderink, F, et al.. (1980). Chronic synovitis with marked infiltration of granulocytes in a patient with an unusual development of systemic lupus erythematosus.. PubMed. 38(7-8). 279–88. 4 indexed citations
17.
Lb, van de Putte, et al.. (1980). Reactive arthritis after Campylobacter jejuni enteritis.. PubMed. 7(4). 531–5. 39 indexed citations
18.
Lb, van de Putte, et al.. (1979). Proliferative lesion of arthritis: a target for therapy?. PubMed. 169–178. 1 indexed citations
19.
Lb, van de Putte, et al.. (1976). Preexisting glomerulonephritis in allografted kidneys. Occurrence in man.. PubMed. 100(4). 196–8. 11 indexed citations
20.
Lb, van de Putte, et al.. (1974). Nephrological aspects of persistent and recurrent haematuria.. PubMed. 17(6). 275–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026